VOYA Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425M Buy
3,052,813
+305,219
+11% +$42.7M 0.44% 44
2025
Q4
$337M Buy
2,747,594
+697,096
+34% +$84.7M 0.33% 58
2025
Q3
$228M Buy
2,050,498
+426,743
+26% +$48.5M 0.23% 97
2025
Q2
$180M Sell
1,623,755
-44,044
-3% -$4.69M 0.18% 133
2025
Q1
$187M Buy
1,667,799
+850,906
+104% +$87.8M 0.21% 113
2024
Q4
$75.5M Sell
816,893
-50,947
-6% -$4.59M 0.08% 257
2024
Q3
$72.8M Sell
867,840
-201,783
-19% -$15.4M 0.08% 258
2024
Q2
$73.4M Sell
1,069,623
-12,912
-1% -$862K 0.07% 262
2024
Q1
$79.3M Sell
1,082,535
-32,424
-3% -$2.49M 0.08% 261
2023
Q4
$90.3M Sell
1,114,959
-27,909
-2% -$2.17M 0.09% 244
2023
Q3
$85.6M Buy
1,142,868
+5,976
+0.5% +$460K 0.09% 240
2023
Q2
$87.6M Sell
1,136,892
-422
-0% -$33.7K 0.09% 246
2023
Q1
$94.4M Sell
1,137,314
-99,399
-8% -$8.23M 0.1% 245
2022
Q4
$106M Sell
1,236,713
-187,404
-13% -$14.8M 0.12% 215
2022
Q3
$87.9M Buy
1,424,117
+416,131
+41% +$26.2M 0.11% 231
2022
Q2
$62.3M Buy
1,007,986
+95,002
+10% +$5.88M 0.16% 138
2022
Q1
$54.3M Buy
912,984
+23,096
+3% +$1.48M 0.11% 171
2021
Q4
$64.6M Buy
889,888
+118,938
+15% +$8.19M 0.12% 159
2021
Q3
$53.9M Sell
770,950
-23,336
-3% -$1.64M 0.11% 178
2021
Q2
$54.7M Sell
794,286
-16,032
-2% -$1.07M 0.11% 193
2021
Q1
$52.4M Sell
810,318
-34,451
-4% -$2.22M 0.11% 181
2020
Q4
$49.2M Buy
844,769
+19,041
+2% +$1.15M 0.1% 189
2020
Q3
$52.2M Buy
825,728
+21,981
+3% +$1.52M 0.12% 173
2020
Q2
$61.8M Sell
803,747
-68,953
-8% -$5.28M 0.14% 160
2020
Q1
$65.2M Sell
872,700
-869,892
-50% -$60.1M 0.18% 134
2019
Q4
$113M Sell
1,742,592
-694,148
-28% -$45.2M 0.23% 99
2019
Q3
$154M Buy
2,436,740
+556,936
+30% +$36.4M 0.34% 64
2019
Q2
$127M Buy
1,879,804
+269,877
+17% +$17.8M 0.27% 87
2019
Q1
$105M Sell
1,609,927
-255,358
-14% -$17M 0.24% 99
2018
Q4
$117M Sell
1,865,285
-76,548
-4% -$5.35M 0.29% 81
2018
Q3
$150M Sell
1,941,833
-28,635
-1% -$2.16M 0.31% 77
2018
Q2
$140M Buy
1,970,468
+131,521
+7% +$9.29M 0.3% 83
2018
Q1
$139M Sell
1,838,947
-1,729,113
-48% -$137M 0.3% 83
2017
Q4
$256M Buy
3,568,060
+34,262
+1% +$2.6M 0.53% 42
2017
Q3
$286M Buy
3,533,798
+2,743,181
+347% +$210M 0.62% 31
2017
Q2
$56M Sell
790,617
-138,850
-15% -$9.24M 0.13% 170
2017
Q1
$63.1M Buy
929,467
+25,061
+3% +$1.76M 0.14% 148
2016
Q4
$64.8M Sell
904,406
-1,634,460
-64% -$121M 0.15% 141
2016
Q3
$201K Sell
2,538,866
-1,492,476
-37% -$121M 0.38% 49
2016
Q2
$336M Buy
4,031,342
+423,027
+12% +$37.5M 0.83% 17
2016
Q1
$331M Buy
3,608,315
+93,113
+3% +$8.4M 0.82% 17
2015
Q4
$356M Sell
3,515,202
-1,170,852
-25% -$122M 0.87% 19
2015
Q3
$460M Buy
4,686,054
+13,004
+0.3% +$1.44M 1.16% 6
2015
Q2
$547M Sell
4,673,050
-174,667
-4% -$19.1M 1.25% 4
2015
Q1
$476M Buy
4,847,717
+1,107,513
+30% +$112M 1.06% 5
2014
Q4
$353M Buy
3,740,204
+72,349
+2% +$7.48M 0.78% 18
2014
Q3
$390M Buy
3,667,855
+106,850
+3% +$10.5M 0.89% 12
2014
Q2
$295M Sell
3,561,005
-2,587,644
-42% -$201M 0.68% 24
2014
Q1
$436M Sell
6,148,649
-101,285
-2% -$7.94M 1.01% 9
2013
Q4
$470M Sell
6,249,934
-425,867
-6% -$29.7M 1.09% 5
2013
Q3
$420M Buy
6,675,801
+123,192
+2% +$7.36M 1.05% 8
2013
Q2
$336M Buy
+6,552,609
New +$342M 0.93% 12

Other funds holding GILD

VOYA Investment Management's GILD Position: Q1 2026 in Review

VOYA Investment Management increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $42.7M and bringing the position to 3,052,813 shares worth $425M. The position accounts for 0.44% of the portfolio, ranked #44.

VOYA Investment Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $547M in Q2 2015. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • VOYA Investment Management held 3,052,813 shares of Gilead Sciences worth $425M as of Q1 2026.
  • VOYA Investment Management bought 305,219 Gilead Sciences shares in Q1 2026, an estimated $42.7M.
  • Gilead Sciences made up 0.44% of VOYA Investment Management's portfolio in Q1 2026, its #44 holding.
  • VOYA Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Gilead Sciences position peaked at $547M in Q2 2015.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.